Agree, Dr. M. is sending a signal to shareholders. He has consistently projected confidence in the A2-73 Homeostasis story for CNS restoration/regeneration. Agree also there is some connection between the PR silence, Biogen and possibly FDA trial guidance reset. Lots of moving parts here and lots of angst but it sure beats waiting 2 years for yet another plaque trial readout after decades of failures.
News 
Market Data 
Discover 
AI
